Sonoma Pharmaceuticals Inc SNOA:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/17/24 EDT
0.24quote price arrow up+0.0058 (+2.4576%)
Volume
313,933
Close
0.236quote price arrow down-0.014 (-5.60%)
Volume
15,201,101
52 week range
0.12 - 1.52
Loading...
  • Open0.29
  • Day High0.30
  • Day Low0.19
  • Prev Close0.25
  • 52 Week High1.52
  • 52 Week High Date06/09/23
  • 52 Week Low0.12
  • 52 Week Low Date11/10/23

Key Stats

  • Market Cap3.683M
  • Shares Out15.61M
  • 10 Day Average Volume1.56M
  • Dividend-
  • Dividend Yield-
  • Beta1.44
  • YTD % Change30.82

KEY STATS

  • Open0.29
  • Day High0.30
  • Day Low0.19
  • Prev Close0.25
  • 52 Week High1.52
  • 52 Week High Date06/09/23
  • 52 Week Low0.12
  • 52 Week Low Date11/10/23
  • Market Cap3.683M
  • Shares Out15.61M
  • 10 Day Average Volume1.56M
  • Dividend-
  • Dividend Yield-
  • Beta1.44
  • YTD % Change30.82

RATIOS/PROFITABILITY

  • EPS (TTM)-0.96
  • P/E (TTM)-0.25
  • Fwd P/E (NTM)-0.36
  • EBITDA (TTM)-3.966M
  • ROE (TTM)-82.87%
  • Revenue (TTM)12.31M
  • Gross Margin (TTM)39.17%
  • Net Margin (TTM)-41.23%
  • Debt To Equity (MRQ)0.66%

EVENTS

  • Earnings Date06/19/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Sonoma Pharmaceuticals Inc

 

Profile

MORE
Sonoma Pharmaceuticals, Inc. is engaged in developing and producing stabilized hypochlorous acid (HOCl), products for a range of applications, including wound care, animal health care, eye care, oral care and dermatological conditions. The Company's product offerings include Regenacyn Advanced Scar Gel, Regenacyn Plus Scar Gel, Rejuvacyn Advanced Skin Repair Cooling Mist, Pediacyn Skin Care, Microcyn, Ocucyn Eyelid and Eyelash Cleanser, Microdacyn60 Oral Care, Podiacyn...
Amy Trombly J.D.
Chief Executive Officer, Director
Bruce Thornton
Chief Operating Officer, Corporate Secretary
Jerry Dvonch
Interim Chief Financial Officer
Address
5445 CONESTOGA COURT, SUITE 150
Boulder, CO
80301
United States